Australia's R&D Incentive: Not A Gift, But A Tax Strategy
Source: Clinical Leader
Mike Burfield explains that the 43.5% R&D incentive is often misunderstood as free money. In reality, it’s a tax program requiring eligible entities, deductible R&D spend, and clear paths to revenue. Foreign sponsors must align tax, corporate, and transfer-pricing rules to benefit.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader